Affymetrix CytoScan Dx Assay

From Aaushi
Jump to navigation Jump to search

Introduction

FDA-approval Jan 2014[1]

Procedure

More general terms

References

  1. 1.0 1.1 FDA News Release: Jan. 17, 2014 FDA allows marketing for first of-its-kind post-natal test to help diagnose developmental delays and intellectual disabilities in children. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm382179.htm